Skip to content
sellWeak cluster of 610b5-1 plan

Daniel Rabinowitz sold $4.6M of NTRA

SEC. AND CHIEF LEGAL OFFICER at Natera, Inc.. 16,800 shares at an average of $272.29, traded Jul 1, 2026, filed Jul 6, 2026.

Warning score
35
Value
$4.6M
16,800 shares
Holdings after
172,294
-9% from before
From 52-week low
+107%
low $133.66, close $276.27
From 52-week high
0%
high $276.27, as of Jul 1, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $4.6M at market
    +25
  • Share of holdings sold
    Sold 8.9% of holdings
    0
  • Cluster
    6 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NTRAOct 9, 2026 · close 400.71
Since filing Jul 6, 2026: +41.2%SPY +3.8% · excess +37.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001857843-26-000016, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-1,568$266.79$418k187,526Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-3,705$268.11$993k183,821Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-1,932$268.99$520k181,889Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-484$269.87$131k181,405Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-1,357$270.96$368k180,048Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-454$272.14$124k179,594Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-500$274.19$137k179,094Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-1,100$275.20$303k177,994Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-1,400$276.24$387k176,594Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-2,045$277.29$567k174,549Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-1,955$278.25$544k172,594Jul 6, 2026
Jul 1, 2026SOpen-market sale
Common Stock10b5-1
-300$278.77$84k172,294Jul 6, 2026

Related signals

Other insiders at Natera, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
38Weak
NTRAsell 310b5-1
Natera, Inc.
Steven Leonard Chapman
CEO AND PRESIDENT
$526k
1,273 shares
-1%
40Moderate
NTRAsell 310b5-1
Natera, Inc.
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS
$1.2M
3,000 shares
-3%
55Moderate
NTRAsell 410b5-1
Natera, Inc.
Jonathan Sheena
director, other
$7.0M
18,064 shares
-100%
35Weak
NTRAsell 410b5-1
Natera, Inc.
Jonathan Sheena
director, other
$3.2M
9,150 shares
-4%
40Moderate
NTRAsell 410b5-1
Natera, Inc.
Matthew Rabinowitz
EXECUTIVE CHAIRMAN
$35M
102,000 shares
-5%
40Moderate
NTRAsell 410b5-1
Natera, Inc.
Matthew Rabinowitz
EXECUTIVE CHAIRMAN
$16M
50,000 shares
-2%
39Weak
NTRAsell 410b5-1
Natera, Inc.
Steven Leonard Chapman
CEO AND PRESIDENT
$545k
1,698 shares
-2%
45Moderate
NTRAsell 410b5-1
Natera, Inc.
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS
$5.9M
18,160 shares
-14%
40Moderate
NTRAsell 710b5-1
Natera, Inc.
John Fesko
PRESIDENT, CHIEF BUS. OFFICER
$2.1M
6,517 shares
-3%
35Weak
NTRAsell 710b5-1
Natera, Inc.
Jonathan Sheena
director, other
$2.0M
6,000 shares
-3%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Daniel Rabinowitz sold $4.6M of NTRA | InsiderTell